Pharmacy Authorization Process
Customize your policy alerts
Sign up for medstarfamilychoicemaryland Policy 218 alerts
Get alerted when Policy 218 changes without checking for updates manually.
Monitor payer policy activity
Governs how medication authorization requests are received, evaluated, decided, and communicated for members, prescribers, dispensing pharmacies, preauthorization staff, and Medical Reviewers.
The maximum approval period for non-controlled medications was revised to 6 to 12 months.
A decision-extension process was added allowing a one-time extension of up to 14 calendar days under specified conditions.
A Wegovy medication prior authorization form was added to the available submission forms.
The procedure was clarified to require categorization of the request reason and documentation of supporting clinical information and outreach attempts.
The procedure was clarified to permit redirection to a formulary-preferred alternative only through a Medical Reviewer or under the Medical Reviewer's direction.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.